Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry
Table 5
Adjusted hazard ratios for 1-year clinical outcomes by proportion of time in therapeutic range for the main analysis and sensitivity analysis (excluding international normalised ratio readings and events during the first 3 months of treatment).